Health Canada approves Risdiplam!
Treatment potential for our pediatric and adult patients! Dear Canada’s SMA community, Cure SMA Canada is happy to share that approval has been issued by Health Canada for Risdiplam for…
Novartis Community Statement – CADTH RECOMMENDATION & ACCESS TO ZOLGENSMA
March 30, 2021 As requested, and as part of our ongoing commitment to keep you informed of important milestones regarding Zolgensma® (onasemnogene abeparvovec), I am writing on behalf of…